Rigel Pharmaceuticals, Inc.

Investors News & Events Contact Us
  • Home
  • Who We Are
    • Company Overview
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Clinical Programs
    • IRAK1/4
    • RIPK1
    • Partnered Programs
    • Clinical Trials
    • Investigator Sponsored Research
    • Expanded Access Policy
  • Products
  • Join Our Team
    • Life at Rigel
    • Our Values
    • Benefits
    • Current Openings
  • Investors
  • News & Events
  • Contact Us

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Oct 28, 2010 7:30am EDT

Rigel Announces Presentations at Two Investor Conferences

Sep 29, 2010 7:30am EDT

Rigel Earns Milestone Payments From AstraZeneca

Sep 09, 2010 7:30am EDT

Rigel to Present at Stifel Nicolaus Healthcare Conference

Aug 03, 2010 7:30am EDT

Rigel Announces Second Quarter 2010 Financial Results

Jul 28, 2010 7:30am EDT

Rigel to Present at BMO Capital Markets Healthcare Conference

Jun 03, 2010 7:30am EDT

Rigel Announces Presentation at Three Investor Conferences

Jun 01, 2010 7:30am EDT

Rigel Pharmaceuticals Names Raul Rodriguez President

May 04, 2010 7:30am EDT

Rigel Announces First Quarter 2010 Financial Results

Apr 30, 2010 7:30am EDT

Rigel Receives Innovators Award of Excellence in Life Sciences

Mar 29, 2010 7:30am EDT

Rigel Announces Expiry of Waiting Period Under Hart-Scott-Rodino Act for Licensing Agreement With Astrazeneca

  • Previous
  • 1…
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …42
  • Next
RSS
Terms of Use Privacy Policy Your Cookie Preferences

© 2025 Rigel Pharmaceuticals, Inc. All Rights Reserved.

TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel Pharmaceuticals, Inc.

Facebook Twitter Linkedin